Showing results (501-510 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinomaJian-jun Li, Mo-fa Gu, Ke Pan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Cytotoxic T-lymphocyte immunotherapy for ovarian cancer: a pilot studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 16, 2011
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumorsJeffrey S Weber, Nicholas J Vogelzang, Marc S Ernstoff, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignanciesTracy R Daniels, Elizabeth Ortiz-Sánchez, Rosendo Luria-Pérez, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
In vitro comparison of three different chimeric receptor-modified effector T-cell populations for leukemia cell therapyIrene Pizzitola, Valentina Agostoni, Elisabetta Cribioli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpressionRenee Vermeij, Geertruida H de Bock, Ninke Leffers, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 18, 2011
Triphenylmethyl derivatives enhances the anticancer effect of immunotoxinsKarianne Risberg, Ingrid Jenny Guldvik, Rahul Palchaudhuri, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
HSCT recipients have specific tolerance to MSC but not to the MSC donorMikael Sundin, A John Barrett, Olle Ringdén, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytesAnjum S Kaka, Donald R Shaffer, Ryan Hartmaier, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic wayChristopher Bachran, Horst Dürkop, Mark Sutherland, et al.Pageof 176